GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 203 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,182,000 | -52.2% | 23,126 | -25.6% | 0.37% | -32.5% |
| Q4 2019 | $2,471,000 | +3.7% | 31,085 | -37.0% | 0.54% | +37.0% |
| Q1 2018 | $2,382,000 | +33.1% | 49,311 | +8.5% | 0.40% | +24.1% |
| Q4 2017 | $1,789,000 | -16.4% | 45,460 | -34.1% | 0.32% | +12.3% |
| Q3 2017 | $2,141,000 | -12.8% | 68,961 | -23.2% | 0.28% | -29.8% |
| Q2 2017 | $2,455,000 | -30.8% | 89,750 | -6.7% | 0.41% | -27.4% |
| Q1 2017 | $3,546,000 | – | 96,225 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |